Oramed, Medpace CRO join hands for oral insulin trial
Pharma | News | By BioSpectrum Bureau | 0 Comment
Singapore: Oramed Pharmaceuticals subsidiary signed an agreement to retain Medpace as the clinical research organization...Read more
Engendering Inclusivity & D...
Can Shorter Regimens Elimin...
Why Singapore is Deep Tech ...
"One example of success is ...
How pharma is finally researching i
3 Practical Ways to Encourage Women
Biocytogen Pharma Beijing and Gilea
Researchers in Asia develop tool to
Japan's Nanophoton strengthens Bruk
China Medical University Hospital i
Is APAC region engendering inclusivity & diversity in life sciences?